Is there 'progression through grade' in ductal invasive breast cancer?

Breast Cancer Research and Treatment

Volumn 135, Issue 3, 2012, Pages 693-703

  Schymik, Barbara ^a,b   Buerger, Horst ^b,c,d   Krämer, Annika ^c   Voss, Ulli ^c   Van Der Groep, Petra ^d   Meinerz, Wolfgang ^a,b   Van Diest, Paul J ^d   Korsching, Eberhard ^e  

^a St Vincenz Hospital   (Germany)

^b Breast Center Paderborn   (Germany)

^c Institute of Pathology   (Germany)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Breast cancer; Breast cancer progression; Estrogen receptor

Indexed keywords

CYCLIN D1; CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER MORPHOLOGY; CANCER SIZE; CELL PROLIFERATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CYCLIN D1; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM GRADING; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84866555705     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2195-1     Document Type: Article

References (33)

1. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403-410
2. Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC (1999) The natural history of breast carcinoma: What have we learned from screening? Cancer 86(3):449-462
3. Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H (2008) Basal carcinoma of the breast revisited: an old entity with new interpretations. J Clin Pathol 61(5):553-560 (Pubitemid 351678206)
4. Vos CB, ter Haar HN, Rosenberg C, Peterse JL, Cleton JA, Cornelisse CJ, van-de Vijver VM (2000) Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer 81(8):1410-1418
5. Mommers EC, van Diest PJ, Leonhart AM, Meijer CJ, Baak JP (1999) Balance of cell proliferation and apoptosis in breast carcinogenesis. Breast Cancer Res Treat 58(2):163-169 (Pubitemid 30032489)
6. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, Van Der WE (2001) Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93(4):309-314 (Pubitemid 32219818)
7. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W (1999) Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189(4):521-526
8. Korsching E, Packeisen J, Helms MW, Kersting C, Voss R, van Diest PJ, Brandt B, Van Der WE, Boecker W, Burger H (2004) Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br J Cancer 90(7):1422-1428 (Pubitemid 38586272)
9. Natrajan R, Lambros MB, Geyer FC, Marchio C, Tan DS, Vatcheva R, Shiu KK, Hungermann D, Rodriguez-Pinilla SM, Palacios J, Ashworth A, Buerger H, Reis-Filho JS (2009) Loss of 16q in high grade breast cancer is associated with estrogen receptor status: evidence for progression in tumors with a luminal phenotype? Genes Chromosomes Cancer 48(4):351-365
10. Korsching E, Packeisen J, Agelopoulos K, Eisenacher M, Voss R, Isola J, van Diest PJ, Brandt B, Boecker W, Buerger H (2002) Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Investig 82(11):1525-1533 (Pubitemid 35332911)
11. Tavassoli FA, Devilee P (eds) (2003) Intraductal proliferative lesions. In: World health organization. Classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon, p 63-73
12. Schnitt SJ, Collins LC (2005) Columnar cell lesions and flat epithelial atypia of the breast. Semin Breast Dis 8:100-111 (Pubitemid 44374377)
13. Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H (2003) Demystified...tissue microarray technology. Mol Pathol 56(4):198-204
14. Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, De Bruin PC, Oudejans JJ, van der Groep P, Hinrichs B, van Diest PJ (2012) Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol 25(3):398-404
15. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W (1999) Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 187(4):396-402 (Pubitemid 29118269)
16. van Deurzen CH, Lee AH, Gill MS, Menke-Pluijmers MB, Jager A, Ellis IO, Rakha EA (2011) Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation? J Pathol 224(4):434-437
17. Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658-663
18. Roylance R, Gorman P, Papior T, Wan YL, Ives M, Watson JE, Collins C, Wortham N, Langford C, Fiegler H, Carter N, Gillett C, Sasieni P, Pinder S, Hanby A, Tomlinson I (2006) A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene 25(49): 6544-6553 (Pubitemid 44607087)
19. Marchio C, Natrajan R, Shiu KK, Lambros MB, Rodriguez-Pinilla SM, Tan DS, Lord CJ, Hungermann D, Fenwick K, Tamber N, Mackay A, Palacios J, Sapino A, Buerger H, Ashworth A, Reis-Filho JS (2008) The genomic profile of HER2-amplified breast cancers: the influence of ER status. J Pathol 216(4):399-407
20. Boulos FI, DupontWD, Schuyler PA, Sanders ME, Page DL, Fedda FA, Simpson JF (2012) Clinicopathologic characteristics of carcinomas that develop after a biopsy containing columnar cell lesions: evidence against a precursor role. Cancer 118(9):2372-2377
21. Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP Jr, Alshak NS, Puligandla B, Brodsky GL, Schnitt SJ, Habel LA (2007) Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol 20(11):1149-1155 (Pubitemid 47609062)
22. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR (2005) Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29(6):734-746 (Pubitemid 40734423)
23. Aroner SA, Collins LC, Schnitt SJ, Connolly JL, Colditz GA, Tamimi RM (2010) Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res 12(4):R61
24. Boulos FI, Dupont WD, Simpson JF, Schuyler PA, Sanders ME, Freudenthal ME, Page DL (2008) Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study. Cancer 113(9):2415-2421
25. Korsching E, Packeisen J, Liedtke C, Hungermann D, Wulfing P, van Diest PJ, Brandt B, Boecker W, Buerger H (2005) The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206(4):451-457 (Pubitemid 41025348)
26. Bryan BB, Schnitt SJ, Collins LC (2006) Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basallike breast cancer. Mod Pathol 19(5):617-621
27. Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC (2007) Identification of a basal-like subtype of breast ductal carcinoma in situ. Hum Pathol 38(2):197-204 (Pubitemid 46096566)
28. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van-de Vijver VM, Zafrani B (1994) Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 11(3):167-180 (Pubitemid 24308077)
29. Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC (2008) Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res 10(4):R67
30. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL (1992) Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 23(9):974-979
31. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A, Medina D (2008) Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14(2):370-378 (Pubitemid 351226103)
32. Buerger H, Simon R, Schaefer KL, Diallo R, Littmann R, Poremba C, van Diest PJ, Dockhorn-Dworniczak B, Boecker W (2000) Genetic relationship of lobular carcinoma in situ, ductal carcinoma in situ and associated invasive carcinoma of the breast. Mol Pathol 53(3):118-121 (Pubitemid 30396450)
33. Boecker W, Buerger H, Schmitz K, Ellis IO, van Diest PJ, Sinn HP, Geradts J, Poremba C, Herbst H (2001) Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 195(4):415-421